Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy
- 30 June 2004
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 81 (6), 1617-1623
- https://doi.org/10.1016/j.fertnstert.2004.02.096
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- A physiologic role for testosterone in limiting estrogenic stimulation of the breastMenopause, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimensClimacteric, 2001
- Effects of Estrogen and Estrogen–Progestin on Mammographic Parenchymal DensityAnnals of Internal Medicine, 1999
- Estradiol and Progesterone Regulate the Proliferation of Human Breast Epithelial CellsFertility and Sterility, 1998
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Steroid hormones and cancer: (II) lessons from experimental systemEuropean Journal of Surgical Oncology, 1997
- Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaquesAmerican Journal of Obstetrics and Gynecology, 1996
- Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperatureThe Journal of Steroid Biochemistry and Molecular Biology, 1982